Whereas both MAPK and PI3K are well known major effector pathways of KRAS, PI3K was shown to be dominantly regulated by RTKs, chiefly IGFR in colorectal and lung cancer [27,28]. This evidence concerns the gene KRAS and lung carcinoma.